HY

Hitendra Yadav

Director Director DIN 00803070
DIN 00803070 First appointment Dec 2006 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2006
Shareholding value •••• Premium profile

About Hitendra Yadav

Data last updated:

Hitendra Yadav was a Director at Pibond Chemie Private Limited (2023–2024) and Director at Deevyalok Pharma Private Limited (2006–2013). The companies operate in Paper and Pharma.

DIN 00803070
Primary Designation Director
Industry Paper
First Appointment 01 Dec 2006

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pibond Chemie Private Limited U21002GJ2023PTC139591
Director27 Mar 20232023Active
Deevyalok Pharma Private Limited U24100MH1984PTC032423
Director01 Dec 20061984Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pibond Chemie Private Limited
Deevyalok Pharma Private Limited
Premium access

Shareholding and investment profile for Hitendra Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hitendra Yadav

Hitendra Yadav was first appointed on 01 Dec 2006 as Director at Deevyalok Pharma Private Limited. The most recent appointment on record is 27 Mar 2023 at Pibond Chemie Private Limited.

Hitendra Yadav held 2 earlier board appointments: Pibond Chemie Private Limited (Director, 27 Mar 2023 to 24 Oct 2024); Deevyalok Pharma Private Limited (Director, 01 Dec 2006 to 04 Apr 2013).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available